Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

Recruiting

Phase 1

Phase 2

Open-Label Study of mRNA-3927 in Participants With Propionic AcidemiaOpen-Label Study of mRNA-3927 in Participants With Propionic Acidemia

Sponsor:

Moderna

Code:

NCT04159103

Conditions

Propionic Acidemia

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

mRNA-3927

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by ModernaTX, Inc. on 2025-03-28.